U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.9898C>T (p.Pro3300Ser) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 14, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001260314.1

Allele description [Variation Report for NM_000059.4(BRCA2):c.9898C>T (p.Pro3300Ser)]

NM_000059.4(BRCA2):c.9898C>T (p.Pro3300Ser)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.9898C>T (p.Pro3300Ser)
HGVS:
  • NC_000013.11:g.32398411C>T
  • NG_012772.3:g.87932C>T
  • NM_000059.4:c.9898C>TMANE SELECT
  • NP_000050.2:p.Pro3300Ser
  • NP_000050.3:p.Pro3300Ser
  • LRG_293t1:c.9898C>T
  • LRG_293:g.87932C>T
  • LRG_293p1:p.Pro3300Ser
  • NC_000013.10:g.32972548C>T
  • NM_000059.3:c.9898C>T
Protein change:
P3300S
Links:
dbSNP: rs770868371
NCBI 1000 Genomes Browser:
rs770868371
Molecular consequence:
  • NM_000059.4:c.9898C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001437238Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Sep 14, 2020)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China.

Hu N, Li WJ, Su H, Wang C, Goldstein AM, Albert PS, Emmert-Buck MR, Kong LH, Roth MJ, Dawsey SM, He LJ, Cao SF, Ding T, Giffen C, Taylor PR.

Cancer Detect Prev. 2003;27(2):132-8.

PubMed [citation]
PMID:
12670525

Infrequent mutation in the BRCA2 gene in esophageal squamous cell carcinoma.

Hu N, Li G, Li WJ, Wang C, Goldstein AM, Tang ZZ, Roth MJ, Dawsey SM, Huang J, Wang QH, Ding T, Giffen C, Taylor PR, Emmert-Buck MR.

Clin Cancer Res. 2002 Apr;8(4):1121-6.

PubMed [citation]
PMID:
11948123
See all PubMed Citations (7)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001437238.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

Variant summary: BRCA2 c.9898C>T (p.Pro3300Ser) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.3e-06 in 273704 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.9898C>T has been reported in the literature in individuals affected with esophageal squamous cell carcinoma and breast cancer (Hu_2002, Ko_2020, Li_2017). These reports do not provide unequivocal conclusions about association of the variant with Hereditary Breast And Ovarian Cancer Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024